Private Wealth Management Group, LLC Denali Therapeutics Inc. Transaction History
Private Wealth Management Group, LLC
- $231 Billion
- Q2 2024
A detailed history of Private Wealth Management Group, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 260 shares of DNLI stock, worth $6,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 24
983.33%
Holding current value
$6,565
Previous $493,000
1124.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DNLI
# of Institutions
214Shares Held
121MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$348 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$333 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$286 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$248 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$180 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.39B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...